Close
Biochemia Medica
MENU
  2. Journal
  3. Volume 30
  4. June, Issue 2
  5. Corrigendum to: Preanalytical issues related to routine and diagnostic glucose tests: Results from a survey in Spain
García-del-Pino, Bauça, Gómez, Caballero, Llopis, Ibarz, Martínez, Ventura, Marzana, Puente, Segovia, Salas, and Gómez-Rioja: Corrigendum to: Preanalytical issues related to routine and diagnostic glucose tests: Results from a survey in Spain

Journal Information

Journal ID (publisher-id): BM

Journal ID (nlm-ta): Biochem Med (Zagreb)

Title: Biochemia Medica

Abbreviated Title: Biochem. Med. (Zagreb)

ISSN (print): 1330-0962

ISSN (electronic): 1846-7482

Publisher: Croatian Society of Medical Biochemistry and Laboratory Medicine

Article Information

Copyright statement: ©Croatian Society of Medical Biochemistry and Laboratory Medicine.

Copyright: 2020, Croatian Society of Medical Biochemistry

License (open-access):

This is an Open Access article distributed under the terms of the Creative Commons Attribution (http://creativecommons.org/licenses/by/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Publication date (electronic): 15 April 2020

Publication date (print): 15 June 2020

Volume: 30

Issue: 2

Electronic Location Identifier: 021201

Related article (corrected article):

Publisher ID: bm-30-2-021201

DOI: 10.11613/BM.2020.021201

Corrigendum to: Preanalytical issues related to routine and diagnostic glucose tests: Results from a survey in Spain

Isabel García-del-Pino[*][1][2]

Josep M. Bauça[1][3]

Carolina Gómez[1][4]

Andrea Caballero[1][5]

María Antonia Llopis[1][6]

Mercedes Ibarz[1][7]

Débora Martínez[1][8]

Montserrat Ventura[1][9]

Itziar Marzana[1][10]

Juan J. Puente[1][11]

Marta Segovia[1][12]

Paloma Salas[1][13]

Rubén Gómez-Rioja[1][14]

[1] Spanish Society of Laboratory Medicine, Extra-analytical Quality Commission, Barcelona, Spain

[2] Area Laboratory, A Coruña University Hospital Complex, A Coruña, Spain

[3] Department of Laboratory Medicine, Son Espases University Hospital, Palma, Balearic Islands, Spain

[4] Department of Clinical Analysis and Biochemistry, Laboratori Clínic Metropolitana Nord, Germans Trias i Pujol Hospital, Badalona, Spain

[5] Preanalytic Area, Department of Clinical Biochemistry, Vall d’Hebron Hospital, Barcelona, Spain

[6] Clinical Laboratories Corporate Coordination, Catalan Health Institute, Barcelona, Spain

[7] Department of Laboratory Medicine, Arnau de Vilanova University Hospital, IRBLleida, Lleida, Spain

[8] Department of Laboratory Medicine, University of Navarra Clinic, Madrid, Spain

[9] External Quality Assurance Programmes, Spanish Society of Laboratory Medicine, Barcelona, Spain

[10] Department of Laboratory, Cruces University Hospital, Barakaldo, Bizkaia, Spain

[11] Department of Biochemistry, ‘Lozano Blesa’ University Clinical Hospital, Zaragoza, Spain

[12] Department of Laboratory Medicine, La Paz-Cantoblanco-Carlos III University Hospital, Madrid, Spain

[13] Department manager of Preanalytical and Extraanalytical Quality phase, Catlab, Viladecavalls, Barcelona, Spain

[14] Department of Laboratory Medicine, La Paz-Cantoblanco-Carlos III University Hospital, Madrid, Spain.

Author notes:

[*] Corresponding author: isabel.garciadelpino.castro@sergas.es

This is a correction of Biochem Med (Zagreb) 2020;30(1):010704. DOI: https://doi.org/10.11613/ BM.2020.010704

Since the publication of the article, the authors have noticed an error in Table 3, Question 5. The correct Table is presented below. The authors apologize for any inconvenience caused to the readers.

Table 3

Information about diagnostic tests

Question 1: Where do you perform OGTT?
At the laboratory 68
At peripheral facilities 9
GDM Screening at peripheral facilities, OGTT at the laboratory 19
Other 4
Question 2: Treatment of OGTT samples:
Centrifugation after each collection, analysis 75
RT, centrifugation after last collection, analysis 20
Refrigerated, centrifugation after the last collection, analysis 5
Other 0
Question 3: What reference values do you use for routine fasting glucose test in adults?
3.9 - 6.05 mmol/L, WHO; 1999 50
3.9 - 5.6 mmol/L, ADA; 2003 34
Other 16
Question 4: What cut-off value do you use in OGTT to diagnose DM in adults?
Fast 8h/OGTT 75g/Glucose 2h 11.1 mmol/L 100
Other 0
Question 5: What cut-off value do you use in OGTT for impaired glucose tolerance?
Fast 8h/OGTT 75g/Glucose 2h 7.8 -11.1 mmol/L 98
Other 2
Question 6: What cut-offs value do you use to diagnose GDM?
ONE STEP: 24-28 week, fast 8h/OGTT 75g/ Basal 7.0 mmol/L; 2h 7.8 mmol/L, WHO; 1999 12
ONE STEP: 24-28 week, fast 8h/ OGTT 75g/ Basal 5.1 mmol/L; 1h 10.0 mmol/L; 2h 8.5 mmol/L, IADPSG;2010, ADA; 2016 10
TWO STEPS: 24-28 week. STEP 1: O’Sullivan test OGO 50g/ 1h glucose 7.8 mmol/L; STEP 2: Fast 8h/OGTT 100g/ Basal 5.8 mmol/L; 1h 10.6 mmol/L; 2h 9.2 mmol/L; 3h 8.0 mmol/L, NDDG; 1979, ADA; 2016, GEDE;2006 56
TWO STEPS: STEP 1: O’Sullivan OGO 50g/ 1h 7.8 mmol/L; STEP 2: fast 8h/OGTT 100 g/ Basal 5.3 mmol/L; 1h 10.0 mmol/L; 2h 8.6 mmol/L; 3h 7.8 mmol/L, Carpenter/Coustan; 1982, ADA; 2016 12
Other* 10
Results are presented as percentage. *Laboratories using two criteria of the previous ones: 4%. Only O’Sullivan test 6%. WHO -
World Health Organization. ADA - American Diabetes Association. OGTT - Oral Glucose Tolerance Test. NDDG - National Diabetes
Data Group. GEDE - Spanish Group of Diabetes and Pregnancy. OGO - Oral glucose overload. IADPSG - International Association of
Diabetes and Pregnancy Study Group.
PDF
HDMBLM
Boškovićeva 18
10000 Zagreb, Croatia

+385 1 48 28 133

Useful links

HDMBLM

Science central

EFLM

Copyright (©) 2010 - 2024 Croatian Society of Medical Biochemistry and Laboratory Medicine. Creative Commons License This work is licensed under a Creative Commons Attribution 4.0 International License

   General terms and conditions of use   |   Cookies   |   RPC